Alborz Nanomed Tech

Alborz Nanomed Technology is a specialized biotechnology company focused on the research, development, and production of nanomedicine-based drug delivery systems. The company utilizes proprietary liposomal and micellar technologies to improve the pharmacokinetic profiles and therapeutic indices of established pharmaceutical compounds. Its lead commercial products include SinaDoxosome, a liposomal formulation of doxorubicin for various cancers, and SinaAmpholeish, a topical treatment for cutaneous leishmaniasis. Alborz Nanomed Technology operates primarily out of the Mashhad University of Medical Sciences Technology Park in Iran. The firm aims to provide high-quality, affordable nanomedicines to address significant health challenges in oncology and infectious diseases.